The Impact of JAK2 V617F CALR and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience.
Frequency of JAK2V617F MPL and CALR driver mutations and associated clinical characteristics in a Norwegian patient cohort with myeloproliferative neoplasms.
Calreticulin Immunohistochemistry in Myeloproliferative Neoplasms - Evolution of a New Cost-Effective Diagnostic Tool: A Retrospective Study with Histological and Molecular Correlation." trans "Calreticulin Immunohistochemistry in Myeloproliferative Neoplasms - Evolution of a New Cost-Effective Diagnostic Tool: A Retrospective Study with Histological and Molecular Correlation.
Screening of somatic mutations in the JAK2 and CALR genes by high-resolution melting curve analysis." trans "capital ES Cyrilliccapital KA Cyrilliccapital ER Cyrilliccapital I Cyrilliccapital EN Cyrilliccapital I Cyrilliccapital EN Cyrilliccapital GHE Cyrillic capital ES Cyrilliccapital O Cyrilliccapital EM Cyrilliccapital A Cyrilliccapital TE Cyrilliccapital I Cyrilliccapital CHE Cyrilliccapital IE Cy...
MOLECULAR GENETIC ABNORMALITIES IN THE GENOME OF PATIENTS WITH Ph-NEGATIVE MYELOPROLIFERATIVE NEOPLASIA AFFECTED BY IONIZING RADIATION AS A RESULT OF THE CHORNOBYL NUCLEAR ACCIDENT." trans "MOLEKULIaRNO-GENETYChNI ANOMALII U GENOMI KhVORYKh NA Rh-NEGATYVNI MIIeLOPROLIFERATYVNI NEOPLAZII IaKI ZAZNALY DII IONIZUIuChOI RADIATsII VNASLIDOK AVARII NA ChAES.
Cytoreductive treatment in patients with CALR-mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia.
Calreticulin has a dual nature and it has been found to be up-regulated or down-regulated in several types of cancer serving as either oncogene or anti-oncogene.
Comprehensive genomic characterization identified distinct genetic subgroups and provided a classification of myeloproliferative neoplasms on the basis of causal biologic mechanisms. Mutations in JAK2 CALR or MPL being the sole abnormality in 45% of the patients.
This study explored the relationship between mutations in the Janus kinase 2 gene ( JAK2) MPL and the calreticulin gene ( CALR) in Uygur and Han Chinese patients with BCR-ABL fusion gene-negative myeloproliferative neoplasms.
We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.